A surveillance-oriented medical record as a source of data for both drug and quality of care surveillance

Pharmacoepidemiology and Drug Safety

Volumn 8, Issue 2, 1999, Pages 131-139

  Maistrello, Italo ^a,d   Di Pietro, Pasquale ^b   Renna, Salvatore ^b   Boscarini, Marina ^b   Nobili, Alessandro ^a,c  

^a ASFE   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d Italo Maistrello   (Italy)

Author keywords

Adverse drug reactions; Adverse events; Continuous quality improvement; Post marketing surveillance

Indexed keywords

ADAPTATION; ARTICLE; DATA BASE; DRUG SURVEILLANCE PROGRAM; HEALTH CARE QUALITY; INFORMATION PROCESSING; MEDICAL RECORD; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0032903790     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199903/04)8:2<131::AID-PDS397>3.0.CO;2-8     Document Type: Article

References (24)

1. Cullen, D. J., Sweitzer, B. J., Bates, D. W., Burdick, E., Edmondson, A. and Leape, L. L. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Critical Care Medicine 1997; 25: 1289-1297.
2. Bates, D. W., Spell, N. and Cullen, D. J. et al. The cost of adverse drug events in hospitalized patients. Journal of the American Medical Association 1997; 277: 307-311.
3. Harchelroad, F. P. Jr, Martin, M. L., Kremen, R. M. and Murray, K. W. Emergency department daily record review: a quality assurance system. Quality Review Bulletin 1988; 14(2): 45-49.
4. Wenzel, R. P. Assessing Quality Health Care -Perspectives for Clinicians. Williams and Wilkins, Baltimore, 1992.
5. Donabedian, A. The quality of care. How can it be assessed? Journal of the American Medical Association 1988; 260: 1743-1748.
6. Classen, D. C., Pestotnik, S. L., Evans, R. S. and Burke, J. P. Computerized surveillance of adverse drug events in hospital patients. Journal of the American Medical Association 1991; 266: 2847-2851.
7. Ornstein, S. M., Jenkins, R. G. and Lee, F. W. et al. The computer-based patient record as a CQI tool in a family medicine center. Journal on Quality Improvement 1997; 23: 347-361.
8. Maistrello, I., Di Pietro, P., Renna, S., Febbrari, M. D. and Natale, L. The drug monitoring-oriented medical record: a new resource for drug surveillance. Drug Information Journal 1993; 27: 1221-1225.
9. Maistrello, I., Febbrari, M. D., Tramontini, M., Maistrello, M. and Natale, L. The multipurpose surveillance-oriented medical record: a tool for quality of care management. International Journal of Quality Health Care 1995; 7: 399-405.
10. Andrew, J. E., Prescott, P. and Smith, T. M. F. Testing for adverse reactions using Prescription Event Monitoring. Statistics in Medicine 1996; 15: 987-1002.
11. Freemantle, S. N., Pearce, G. L., Wilton, L. W., Mackay, B. M. and Mann, R. D. The incidence of the most commonly reported events with 40 newly marketed drugs - a study by Prescription-Event Monitoring. Pharmacoepidemiology and Drug Safety 1997; 6(Suppl. 1): 1-8.
12. Wadsworth, H. M., Stephens, K. S. and Godfrey, A. B. Modern Methods for Quality Control and Improvement. John Wiley & Sons, 1986.
13. Laffel, G. and Blumenthal, D. The case for using industrial quality management science in health care organisations. Journal of the American Medical Association 1989; 262: 2869-2873.
14. Berwick, D. M. Controlling variation in health care: a consultation from Walter Shewhart. Medical Care 1991; 29: 1212-1225.
15. Praus, M., Schindel, F., Fescharek, R. and Schwarz, S. Alert systems for post-marketing surveillance of adverse drug reactions. Statistics in Medicine 1993; 12: 2383-2393.
16. Lipman, A. G. Monitoring and reporting ADRs: one institution's approach. Hospital Formul 1988; 23: 835.
17. Vorce-West, T. E., Barstow, L. and Butcher, B. System for voluntary reporting of adverse drug reactions in a university hospital. American Journal of Hospital Pharmacy 1989; 46: 2300-2303.
18. Scott, H. D., Thacher-Renshaw, A. and Rosenbaum, S. E., et al. Physician reporting of adverse drug reactions: results of the Rhode Island adverse drug reactions reporting project. Journal of the American Medical Association 1990; 263: 1785-1788.
19. Maistrello, I., Morgutti, M., Maltempi, M. and Dantes, M. Adverse drug reactions in hospitalized patients: an operational procedure to improve reporting and investigate underreporting. Pharmacoepidemiology and Drug Safety 1995; 4: 101-106.
20. Rogers, A. S., Israel, E. and Smith, C. R., et al. Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Archieves of Internal Medicine 1988; 148: 1596-1600.
21. Inmann, W. H. W. Postmarketing surveillance of adverse drug reactions in general practice I: search for new methods. British Medical Journal 1981; 282: 1131-1132.
22. Berwick, D. M. Continuous improvement as an ideal in health care. New England Journal of Medicine 1989; 320: 53-56.
23. Kritchevsky, S. B. and Simmons, B. P. Continuous quality inprovement: concepts and applications for physician care. Journal of the American Medical Association 1991; 266: 1817-1823.
24. Smith, R. What clinical information do doctors need? British Medical Journal 1996; 313: 1062-1068.